Hired and Retired: Year's end edition
(Image: Getty/masterzphotois)
As 2018 comes to a close, members of the industry are preparing to take on new roles for the upcoming year.
Former GW Pharmaceuticals executive, Rupert Haynes, will follow the successful approval of Epidiolex by taking on a new position as CEO.
In another significant move in the industry sees the chief executive of UK regulator, MHRA, leave his position, after working in the industry for nearly 29 years.
